Monitoring Biomarkers of Cellular Injury and Death in Acute Brain Injury

Conclusion Current studies vary significantly in patient selection, biosample collection/processing, and biomarker measurement protocols, thereby limiting the generalizability of overall results. Future large prospective studies with standardized treatment, biosample collection, and biomarker measurement and validation protocols are necessary to identify high-fidelity biomarkers in neurocritical care.
Source: Neurocritical Care - Category: Neurology Source Type: research